Publications by authors named "Clive Mason"

Claim this Profile
T
The Novel DNA Binding Mechanism of Ridinilazole, a Precision Antibiotic.
Clive S Mason, Tim Avis, Chenlin Hu, Nabeetha Nagalingam, Manikhandan Mudaliar

Antimicrob Agents Chemother· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections.
Mark A T Blaskovich, Karl A Hansford, Mark S Butler, Soumya Ramu, Angela M Kavanagh, Clive Mason

Sci Transl Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted microbiome-sparing antibiotics.
Tim Avis, Francis X Wilson, Nawaz Khan, Clive S Mason, David J Powell

Drug Discov Today· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-density transposon libraries utilising outward-oriented promoters identify mechanisms of action and resistance to antimicrobials.
Chris Coward, Gopujara Dharmalingham, Omar Abdulle, Tim Avis, Stephan Beisken, Clive Mason

FEMS Microbiol Lett· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High in vitro activity of DIS-73285, a novel antimicrobial with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae.
Susanne Jacobsson, Clive Mason, Nawaz Khan, Paul Meo, Magnus Unemo

J Antimicrob Chemother· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of the novel oral antimicrobial SMT-571, with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae: future treatment option for gonorrhoea?
Susanne Jacobsson, Clive Mason, Nawaz Khan, Paul Meo, Magnus Unemo

J Antimicrob Chemother· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning-powered antibiotics phenotypic drug discovery.
Sannah Zoffmann, Maarten Vercruysse, Fethallah Benmansour, Andreas Maunz, Luise Wolf, Clive S Mason

Sci Rep· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-resistant aurora A mutants for cellular target validation of the small molecule kinase inhibitors MLN8054 and MLN8237.
Dominic A Sloane, Michael Z Trikic, Matthew L H Chu, Maria B A C Lamers, Clive S Mason

ACS Chem Biol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF.
Victoria Emuss, Mathew Garnett, Clive Mason, Richard Marais

Cancer Res· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of a dominant negative retinoic acid receptor γ in Xenopus embryos leads to partial resistance to retinoic acid.
Darrin Paul Smith, Clive Scott Mason, Elizabeth Jones, Robert Old

Rouxs Arch Dev Biol· March 1994

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis